2invest
VC Fund
Mahé, Seychelles
2invest is a VC fund in Mahé focused on Biotechnology and Simulation. 2invest.com, a leading financial services company, offers a variety of online trading opportunities for traders and investors. The diverse community of traders can choose to explore CFD trading on various vehicles such as cryptocurrencies, forex, indices, shares and commodities. The company has several trading portals for ease in investing –online, web-based, and mobile trading. This gives traders full capability to trade on iOS, Android, tablets, mobile phones, PCs and MACs. 2invest.com prides itself on its range of assets and dedication to above-standard security, safety, flexibility, innovation and transparency. Traders’ funds are kept separate form company funds in top-tier banking institutions, and a full complement of computer security is utilized to prevent cyber security attacks or fraud of any kind. As an international site, 2invest.com focuses on the user experience and understands the importance of providing professional, knowledgeable customer service personnel who can handle issues, questions, and concerns of traders. This is offered in several languages as necessitated by a global user base, 24/5. A full range of educational tools are offered to give traders the background they need to become strong investors. The offering includes webinars, one-on-one learning, glossaries and FAQs, ebooks and courses, in addition, within the portals themselves, traders can find a wealth of analytic tools as well has histories and other pertinent information.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries 2invest invests in
Stages 2invest invests in
Countries 2invest invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Simulation 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Translation Service 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Leucid Bio
|
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part ofLeucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts. | $15.9M / Series A / Oct 21, 2021 | |
NeoPhore
|
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms,enabling cancer patients to get treated and achieve improved clinical outcomes. | $21.1M / Series B / Mar 09, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does 2invest invest in?
2invest invests primarily in Biotechnology, Simulation and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did 2invest last invest?
The most recent investment recorded for 2invest closed in Oct 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
